(Q73670404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

cervix uterine cancer

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

G B Wisman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A J Knol

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M N Helder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Krans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Hollema

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S de Jong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A G van der Zee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

658-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

Molecular biology of cervical cancer and its precursors

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Surgically-treated early cervical cancer: Prognostic factors and the significance of depth of tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activation by the E6 gene product of human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity and survival of patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity in ordinary meningiomas predicts poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

A mammalian telomerase-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase catalytic subunit homologs from fission yeast and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Reconstitution of human telomerase activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Extension of life-span by introduction of telomerase into normal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

A telomerase component is defective in the human disease dyskeratosis congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity and prognosis in primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase activity and prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Telomerase targeting in cancer treatment: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Inhibition of human telomerase activity by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Inhibition of human telomerase by 2'-O-methyl-RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1099%3E3.0.CO%3B2-7

10.1002/1097-0215(200002)9999:9999<::AID-IJC1099>3.0.CO;2-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267977%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference